- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | MICROBA LIFE SCIENCES LIMITED: Date of AGM and Closing Date for Director Nominations | - | ASX | ||
| 19.09. | MICROBA LIFE SCIENCES LIMITED: Change of Director's Interest Notice - G Tyson & H Kim | - | ASX | ||
| 18.09. | MICROBA LIFE SCIENCES LIMITED: Change of Director's Interest Notice - Richard Bund | 3 | ASX | ||
| 16.09. | MICROBA LIFE SCIENCES LIMITED: Change of Director's Interest Notice - Richard Bund | - | ASX | ||
| 01.09. | MICROBA LIFE SCIENCES LIMITED: Change in substantial holding | - | ASX | ||
| 26.08. | Microba Life Sciences Reports Revenue Growth, Reduced Losses in Preliminary Final Report | 1 | Finance News Network | ||
| MICROBA LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 26.08. | MICROBA LIFE SCIENCES LIMITED: 2025 Annual Report & Appendix 4E | - | ASX | ||
| 26.08. | MICROBA LIFE SCIENCES LIMITED: 2025 Corporate Governance Statement | - | ASX | ||
| 26.08. | MICROBA LIFE SCIENCES LIMITED: 2025 Appendix 4G | - | ASX | ||
| 19.08. | MICROBA LIFE SCIENCES LIMITED: Notice of change of Interests of substantial holder from SHL | 1 | ASX | ||
| 19.08. | MICROBA LIFE SCIENCES LIMITED: Change in substantial holding | 2 | ASX | ||
| 15.08. | MICROBA LIFE SCIENCES LIMITED: Corrected Change of Director's Interest Notice | 1 | ASX | ||
| 15.08. | MICROBA LIFE SCIENCES LIMITED: Change of Director's Interest Notice - Pasquale Rombola | - | ASX | ||
| 15.08. | MICROBA LIFE SCIENCES LIMITED: Change of Director's Interest Notice - Prof Ian Frazer | 1 | ASX | ||
| 13.08. | MICROBA LIFE SCIENCES LIMITED: Cleansing Notice | - | ASX | ||
| 13.08. | MICROBA LIFE SCIENCES LIMITED: Notification regarding unquoted securities - MAP | - | ASX | ||
| 13.08. | MICROBA LIFE SCIENCES LIMITED: Notification regarding unquoted securities - MAP | - | ASX | ||
| 13.08. | MICROBA LIFE SCIENCES LIMITED: Notification regarding unquoted securities - MAP | 1 | ASX | ||
| 13.08. | MICROBA LIFE SCIENCES LIMITED: Application for quotation of securities - MAP | - | ASX | ||
| 13.08. | MICROBA LIFE SCIENCES LIMITED: Application for quotation of securities - MAP | - | ASX |
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MINERALYS THERAPEUTICS | 42,800 | 0,00 % | Mineralys Therapeutics: Aktie erreicht Rekordhoch von 41,11 USD | ||
| QIAGEN | 40,610 | -0,84 % | QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast | QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) today announced plans to release results for the third quarter of 2025.
Press release date time: Tuesday, November 4, shortly after 22:05... ► Artikel lesen | |
| TARSUS PHARMACEUTICALS | 69,83 | -0,72 % | Tarsus Pharmaceuticals, Inc: Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements | Record quarterly net product sales of $102.7 million achieved within two years of our XDEMVY® launch, an increase of 152% year over year Direct-To-Consumer campaign has activated new patients, expanded... ► Artikel lesen | |
| BEAM THERAPEUTICS | 25,420 | 0,00 % | Jefferies stuft Beam Therapeutics auf "Buy": Kommende Katalysatoren im Fokus | ||
| ARCELLX | 87,33 | 0,00 % | Arcellx, Inc.: Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 | Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, today announced... ► Artikel lesen | |
| RECURSION PHARMACEUTICALS | 5,885 | 0,00 % | RECURSION PHARMACEUTICALS INC zündet den Turbo jetzt! | ||
| ARS PHARMACEUTICALS | 10,660 | 0,00 % | ARS Pharmaceuticals, Inc.: ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy (epinephrine nasal spray) | SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to... ► Artikel lesen | |
| BIONTECH | 88,50 | +0,11 % | BioNTech Aktie: Jetzt kommt die Wende! | © Foto: Foto von CDC auf Unsplash (Symbolbild)Die BioNTech-Aktie steht vor einem spannenden Wendepunkt. Nach turbulenten Zeiten hat sich der Kurs stabilisiert und zeigt erste Anzeichen einer nachhaltigen... ► Artikel lesen | |
| EVOTEC | 6,586 | -2,95 % | BioNxt Solutions, Bayer, Evotec - Enormes Upside! Schnittstelle von Biotech und Pharma! | Die weltweite Zunahme von Wohlstandserkrankungen wie Diabetes, Adipositas, Multipler Sklerose (MS) und MASH (metabolisch bedingte Fettleber) sorgt für ein enormes Wachstum im Gesundheitssektor. Ebenso... ► Artikel lesen | |
| KINIKSA PHARMACEUTICALS | 37,890 | +2,41 % | Earnings Call: Kiniksa Pharmaceuticals meldet starkes Wachstum im zweiten Quartal 2025 und hebt Prognose an | ||
| ADMA BIOLOGICS | 14,950 | +2,75 % | ADMA Biologics, Inc.: ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update | 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted... ► Artikel lesen | |
| DYNE THERAPEUTICS | 15,465 | 0,00 % | Dyne cut to Perform at Oppenheimer on valuation | ||
| STRUCTURE THERAPEUTICS | 30,220 | +0,10 % | Aktien New York: Weitere Rekorde - auch dank Nvidia und Apple | NEW YORK (dpa-AFX) - Die US-Börsen haben am Montag nach einem verhaltenen Start ihre Rekordjagd fortgesetzt. Auch dank deutlicher Kursgewinne der Schwergewichte Nvidia und Apple verzeichnete der Leitindex... ► Artikel lesen | |
| MODERNA | 22,760 | -4,33 % | Moderna, Inc.: Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress | mRNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety... ► Artikel lesen | |
| CG ONCOLOGY | 42,840 | 0,00 % | Why Cg Oncology Stock Rocketed 7% Higher Today |
Das Unternehmen MICROBA LIFE SCIENCES LIMITED kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 0,043 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MICROBA LIFE SCIENCES LIMITED finden Sie auf Wallstreet Online.